A Study to Assess Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Conditions: Limited-stage Small Cell Lung Cancer (LS-SCLC) Interventions: Drug: Tifcemalimab injection; Drug: toripalimab injection; Drug: Placebo for Tifcemalimab; Drug: Placebo for toripalimab Sponsors: Shanghai Junshi Bioscience Co., Ltd. Not yet recruiting

https://clinicaltrials.gov/study/NCT06095583

Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials